Cairn Diagnostics to Attend Digestive Disease Week® (DDW) 2026

Cairn Diagnostics to Attend Digestive Disease Week® (DDW) 2026

Cairn Diagnostics is excited to announce our participation in Digestive Disease Week® (DDW) 2026, taking place May 2–5 in Chicago, IL, and online. As one of the premier global gatherings for gastroenterology, hepatology, endoscopy, and GI surgery, DDW brings together thousands of healthcare professionals committed to advancing digestive health.

With more than 300 exhibitors, cutting-edge scientific sessions, and valuable networking opportunities, DDW is a key event for providers looking to stay at the forefront of innovation in GI care.

Visit Cairn Diagnostics at Booth #2237

Attendees are invited to visit Booth #2237 to connect with members of the Cairn Diagnostics team, including:

  • Gate Hogan, Chief Commercial Officer
  • Maria French, Inside Sales Representative – GEBT

Our team will be available to discuss how Cairn is helping providers improve the diagnosis of gastroparesis through innovative, patient-friendly solutions.

Advancing Gastroparesis Diagnosis with the GEBT

At DDW 2026, Cairn Diagnostics will highlight the Gastric Emptying Breath Test (GEBT)—the first and only FDA-approved, guideline-recommended breath test for diagnosing gastroparesis.

The GEBT was developed to address longstanding challenges in gastric emptying studies, including variability, limited access to nuclear imaging, and patient discomfort.

Why Providers Are Turning to The GEBT:

  • Non-invasive and radiation-free
  • Standardized and clinically validated
  • Accessible via in-office or telehealth delivery
  • Results returned in as little as 2 business days

By removing the need for radioactive materials and specialized imaging equipment, the GEBT offers a practical alternative that fits seamlessly into modern clinical workflows.

Expanding Access to Diagnostic Care

One of the key themes at DDW is improving access to care—and that’s central to Cairn’s mission.

With telehealth-enabled testing, providers can offer gastric emptying studies to patients who may otherwise face barriers such as long wait times, travel limitations, or lack of access to nuclear medicine facilities.

This approach supports:

  • Faster time to diagnosis
  • Improved patient experience
  • Greater equity in GI care delivery

Let’s Connect at DDW 2026

Whether you’re exploring new diagnostic tools, looking to streamline your practice, or seeking better options for your patients, we invite you to stop by Booth #2237.

Our team is eager to share how Cairn Diagnostics is helping providers bring clarity, consistency, and convenience to gastroparesis diagnosis.

About Cairn Diagnostics

Cairn Diagnostics is dedicated to providing safe, scalable, and scientifically validated tools for diagnosing delayed gastric emptying. By replacing outdated, radiation-based methods with innovative breath testing technology, Cairn is helping clinicians deliver better care—while improving access for patients everywhere.